The British system for dementia care in residential facilities relies on a blurred line between health needs and social needs. This distinction determines who pays, how much, and under what rules, with notable discrepancies between England, Scotland, and Wales.
NHS Continuing Healthcare and dementia: increasingly difficult funding to obtain
NHS Continuing Healthcare (CHC) remains the only mechanism that allows for full coverage of accommodation and care costs by the public health system. To qualify, the resident must demonstrate a primary health need recognized as predominant over their social needs.
See also : Understanding the simulation of salary portage: an essential tool for independent workers
Since 2023-2024, several English local authorities have been applying this distinction more strictly. The result: highly dependent profiles, including individuals with advanced dementia, are being denied CHC and shifted to social funding subject to a means test. We observe that this trend particularly affects residents whose cognitive impairments are severe but whose somatic medical needs are deemed moderate.
The assessment process relies on a standardized tool, the Decision Support Tool, which examines a dozen areas (cognition, behavior, continence, nutrition, mobility, among others). Each area is rated according to four levels of severity. A single area rated as “priority” or several areas rated as “severe” may be sufficient to trigger eligibility, but interpretation varies from one local authority to another.
You may also like : Women in Automotive: When Women Take the Wheel of Innovation
For families contesting a CHC denial, the review process can take several months. Finding information on Seniors Connexion helps to better understand the administrative steps of this journey.
Means testing in England: thresholds and out-of-pocket costs for residents with dementia
When CHC is denied, funding shifts to the local authority’s social services. The resident then undergoes a means test that determines their financial contribution.
Property assets are included in the calculation, except when a spouse, a family member over 60, or a disabled person continues to reside there. This point generates frequent concern among families, as evidenced by testimonies collected on British forums: the fear of having to sell the family home is recurrent, even though the protection of the resident spouse is explicitly provided for by regulation.
The self-funding resident pays all costs as long as their capital exceeds the upper threshold. Once below the lower threshold, the local authority covers the difference. Between the two thresholds, a sliding scale contribution applies.
- The capital considered includes savings, investments, and, where applicable, the value of the property (excluding protections for spouses or vulnerable individuals)
- Pension income is considered as revenue and contributes to the payment of fees, except for a weekly personal allowance left to the resident
- Local authorities may offer a deferred payment agreement secured against the property, allowing the resident to avoid selling their home while alive
Scotland and Wales: different rules for identical clinical profiles
A resident with dementia presenting exactly the same clinical profile will not pay the same out-of-pocket costs depending on whether they reside in England or Scotland. Scotland applies the principle of free personal and nursing care for individuals over 65. Personal care (help with washing, dressing, eating) and nursing care are covered, regardless of resource levels.
The cost of pure accommodation (housing, meals) remains the responsibility of the resident, subject to resource conditions for supplementary assistance. This structure inherently creates a lower out-of-pocket cost for Scottish residents with dementia compared to their English counterparts, where personal care does not benefit from the same universal coverage.
Wales and Northern Ireland have their own scales and thresholds. Each of the four countries in the UK pursues its own policy for funding adult social services, making any generalization misleading.
Cross-border placements and alternatives to the British system
Financial pressure is prompting some families to consider solutions outside the UK. Several recent reports, including one from Alzheimer’s Disease International (“From Plan to Impact V”, 2023), document a trend towards placements in Eastern Europe for British individuals with dementia. Accommodation costs there are significantly lower.
This practice raises serious questions about quality control of care and residents’ rights. Facilities located outside the UK are not subject to inspection by the Care Quality Commission (CQC) or its Scottish or Welsh equivalents. In cases of abuse or neglect, legal recourse is more complex and slower.
We recommend that families exploring this route verify the existence of a local inspection body, the qualifications of the care staff in dementia care, and the contractual exit conditions. The cost differential should not obscure a differential in legal protection.
Dementia funding in the UK: what really weighs on families
The total cost is not limited to the displayed accommodation fees. Additional charges for specialized dementia care (secure units, higher staff-to-resident ratios, therapeutic activities) increase the bill. Facilities often charge a surcharge for residents in protected living units compared to those in standard accommodation.
- Laundry, hairdressing, and accompanied outings are rarely included in the base rate
- Regular needs assessments can lead to a reclassification of fees during the stay, without the family having anticipated this increase
- The length of stay in a facility for a person with dementia often exceeds that of other residents, which multiplies the cumulative financial impact
The combination of increasingly restricted access to CHC, resource thresholds that do not keep pace with rising accommodation costs, and specific surcharges for dementia creates a financial burden that few British families anticipate at the time of admission.